Company Overview of Progen Pharmaceuticals, Inc.
Key Executives for Progen Pharmaceuticals, Inc.
|Thomas D. Kiley Esq.||16 Relationships||Co-Founder and Director||74|
Progen Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Thomas D. Kiley Esq.||16 Relationships||Progen Pharmaceuticals, Inc.||74|
|Michael G. Raab||30 Relationships||Ardelyx, Inc.||52|
|Anthony E. Pegg Ph.D.||6 Relationships||Progen Pharmaceuticals, Inc.||--|
|Randall K. Johnson Ph.D.||78 Relationships||TetraLogic Pharmaceuticals Corporation||70|
|Daniel Douglas Von Hoff M.D., F.A.C.P.||508 Relationships||Oncology Venture Sweden AB||69|
Progen Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|There is no committee data available.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.